Advertisement

Topics

Clearside completes enrollment in trial of noninfectious uveitis treatment

11:00 EDT 8 Aug 2017 | Healio

Patient enrollment in the phase 3 PEACHTREE trial of a treatment for macular edema associated with noninfectious uveitis has been completed, according to a press release from Clearside Biomedical. The randomized, masked, sham-controlled clinical trial has enrolled 160 patients and is evaluating the efficacy of suprachoroidal CLS-TA, a proprietary suspension formulation of triamcinolone acetonide.

Original Article: Clearside completes enrollment in trial of noninfectious uveitis treatment

NEXT ARTICLE

More From BioPortfolio on "Clearside completes enrollment in trial of noninfectious uveitis treatment"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...